Aktie A011040 KYUNG DONG PHARMACEUTICAL CO., LTD.
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Kyung Dong Pharmaceutical Co., Ltd.

Aktien

A011040

KR7011040003

A011040

Schlusskurs Korea S.E.
Andere Börsenplätze
 00:00:00 16.05.2024 		% 5 Tage % 1. Jan.
6’490 KRW +1.25% Intraday Chart für Kyung Dong Pharmaceutical Co., Ltd. +2.04% -1.82%
21.03. Kyung Dong Pharmaceutical Co., Ltd. meldet Ergebnis für das am 31. Dezember 2023 endende Geschäftsjahr CI
30.01. Kyung Dong Pharmaceutical Co., Ltd. (KOSDAQ:A011040) gibt einen Aktienrückkauf für 200.000 Aktien bekannt. CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Tranche Update on Kyung Dong Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on January 30, 2024.
Tranche Update on Kyung Dong Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on January 30, 2024.
Kyung Dong Pharmaceutical Co., Ltd.'s Equity Buyback announced on January 30, 2024, has closed with 200,000 shares, representing 0.74% for KRW 1,278.39 million.
Kyung Dong Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
Kyung Dong Pharmaceutical Co., Ltd. announces an Equity Buyback for 200,000 shares.
Kyung Dong Pharmaceutical Co., Ltd. authorizes a Buyback Plan.
Kyung Dong Pharmaceutical Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
Kyung Dong Pharmaceutical Co., Ltd.(KOSDAQ:A011040) dropped from S&P Global BMI Index
Kyung Dong Pharmaceutical Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
Kyung Dong Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
Kyung Dong Pharmaceutical Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
Tranche Update on Kyung Dong Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on September 16, 2022.
Kyung Dong Pharmaceutical Co., Ltd.'s Equity Buyback announced on September 16, 202, has closed with 100,000 shares, representing 0.37% for KRW 749.64 million.
Kyung Dong Pharmaceutical Co., Ltd. announces an Equity Buyback for 100,000 shares.
Kyung Dong Pharmaceutical Co., Ltd. authorizes a Buyback Plan.
Kyung Dong Pharmaceutical Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
Kyung Dong Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022
Eight South Korean Firms to Donate $2.4 Million Worth of Medicine to Ukraine
Kyung Dong Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021
Kyung Dong Pharmaceutical Co., Ltd.'s Equity Buyback announced on August 17, 2021, has expired.
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A011040 Aktie
  4. Nachrichten Kyung Dong Pharmaceutical Co., Ltd.
  5. Andere Sprachen